A new study is exploring whether accelerated iTBS for adolescent depression can deliver rapid symptom improvement without requiring families to sustain an intensive treatment schedule for an extended period. Published in Translational Psychiatry, the research adds to growing interventional psychiatry research examining how neuromodulation protocols can be adapted for younger patients while remaining practical in real-world care.
Why Adolescent Depression Needs More Flexible Treatment Options
Major depressive disorder during adolescence can interfere with school, relationships, development, and daily functioning. Standard treatments generally include psychotherapy and antidepressant medication, but not every patient responds adequately, and improvement can take time.
Intermittent theta burst stimulation, or iTBS, is a form of transcranial magnetic stimulation that delivers patterned magnetic pulses to targeted cortical regions. Its relatively short treatment sessions make it attractive for developing more intensive schedules.
Accelerated approaches provide multiple iTBS sessions per day, potentially compressing treatment into a shorter period. The challenge is practicality. Repeated daily visits can create substantial scheduling, transportation, school, and family burdens.
A Hybrid Model Combines Rapid Treatment With Maintenance
Researchers led by Zhinan Yu and colleagues tested a hybrid protocol intended to balance treatment intensity with feasibility.
Thirty-two adolescents with major depressive disorder completed a two-day accelerated treatment phase followed by four weeks of maintenance iTBS. Participants underwent clinical and neuroimaging evaluations at baseline, after the accelerated phase, and at the end of treatment. Researchers also included 34 age- and sex-matched healthy participants for baseline brain imaging comparisons.
This design allowed the team to examine both clinical improvement and whether treatment was associated with measurable changes in brain function.
Accelerated iTBS For Adolescent Depression Produced Significant Symptom Reductions
Depressive symptoms decreased significantly during the study, as measured by the Montgomery-Asberg Depression Rating Scale.
By the end of treatment, 62.5 percent of participants met criteria for clinical response, while 54.2 percent met criteria for remission. These results are encouraging, particularly because the protocol combined a brief intensive phase with a less demanding maintenance period rather than concentrating the entire intervention into several consecutive high-intensity days.
Supplementary analyses comparing active accelerated iTBS with sham stimulation also found significantly greater reductions in MADRS scores with active treatment. However, the primary hybrid accelerated-maintenance treatment cohort was not itself a randomized sham-controlled trial.
The findings should still be considered preliminary because the primary treatment cohort was relatively small.
Brain Imaging Revealed Changes Across Large-Scale Networks
The researchers also investigated how treatment might influence neural function.
Before treatment, adolescents with depression showed widespread differences in the amplitude of low-frequency fluctuations, a resting-state functional MRI measure associated with spontaneous brain activity. They also demonstrated altered functional connectivity across several large-scale neural networks.
Following treatment, many of these abnormalities changed significantly. By study completion, most were no longer statistically different from patterns observed in the healthy comparison group.
This does not necessarily mean that iTBS permanently normalized the brain. Instead, the imaging results suggest that clinical improvement occurred alongside measurable shifts in neural systems implicated in depression.
Why The Neural Findings Matter
Depression is increasingly understood as a disorder involving distributed brain networks rather than dysfunction within a single isolated region. Communication among networks involved in cognitive control, emotion regulation, self-referential processing, and attention may contribute to depressive symptoms.
TMS targets a specific cortical region, but its effects can propagate through connected networks. The observed functional connectivity changes therefore provide a potential biological framework for understanding how localized stimulation might influence broader depressive circuitry.
A Different Approach To Accelerated Neuromodulation
The study is notable because it does not simply ask whether more stimulation can produce faster improvement. Instead, it examines whether treatment intensity can be strategically distributed.
A short accelerated phase may initiate symptom improvement, while maintenance sessions could reinforce those effects without requiring adolescents to continue a highly intensive schedule. For younger patients, this balance between efficacy and treatment burden may be especially important.
Other research has also supported the feasibility of iTBS in adolescents with major depressive disorder, including randomized studies examining accelerated stimulation for clinically significant symptoms such as non-suicidal self-injury.
What Comes Next For Adolescent iTBS
Larger randomized trials will be necessary to determine how consistently the hybrid protocol performs, how durable remission remains after treatment ends, and which adolescents are most likely to benefit.
Future studies may also clarify whether neuroimaging changes can become biomarkers that help clinicians personalize stimulation targets, treatment intensity, or maintenance schedules.
For now, the findings provide early evidence that accelerated iTBS for adolescent depression may not need to rely exclusively on prolonged high-intensity treatment schedules. A hybrid model combining rapid intervention with structured maintenance could represent a practical direction for the next generation of youth neuromodulation research.
Citations
- Yu Z, Zhang B, Sun Y, et al. Clinical and neural effects of a hybrid accelerated-maintenance iTBS protocol in adolescents with major depressive disorder. Translational Psychiatry. 2026. https://doi.org/10.1038/s41398-026-04380-0
- Qin Y, Chen H, Liu F, et al. Intermittent theta burst stimulation for non-suicidal self-injury in adolescents with major depressive disorder: a randomized controlled trial. Molecular Psychiatry. Published August 29, 2025. https://www.nature.com/articles/s41380-025-03183-x
Explore more at https://www.interventionalpsychiatry.org/
